Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 4Unknown 2Withdrawn 1Recruiting 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 4354Neoplasms 3056Prostatic Neoplasms 1904Colorectal Neoplasms 1739Lung Neoplasms 1555Carcinoma, Non-Small-Cell Lung 1270Pancreatic Neoplasms 981Leukemia, Myeloid, Acute 952Multiple Myeloma 951Lymphoma 912Head and Neck Neoplasms 894Leukemia 852Precursor Cell Lymphoblastic Leukemia-Lymphoma 833Neoplasm Metastasis 793Colonic Neoplasms 785Carcinoma, Hepatocellular 762Ovarian Neoplasms 757Melanoma 752Stomach Neoplasms 742Rectal Neoplasms 701Brain Neoplasms 696Lymphoma, Non-Hodgkin 663Leukemia, Lymphocytic, Chronic, B-Cell 618Uterine Cervical Neoplasms 607Lymphoma, Follicular 559Glioblastoma 541Recurrence 539Hodgkin Disease 532Esophageal Neoplasms 527Myelodysplastic Syndromes 508

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × OTHER × Peripheral Arterial Disease × Clear all
NCT03960463 2025-01-23

EO2 Oxygen Delivery To Study Success Rate of Surgically Closed Wounds

Baylor College of Medicine

Phase NA Completed
33 enrolled 13 charts
Breast

Surgical Wound, Breast Neoplasms, Cicatrix, Diabetes Mellitus, Infections, Diabetic Foot, Peripheral Arterial Disease

NCT06234280 2024-01-31

K-ELUVIA

Yonsei University

Completed
100 enrolled
Lymphoid

Chronic Limb-Threatening Ischemia, Intermittent Claudication, Lymphoma, Follicular, Peripheral Arterial Disease

NCT05116696 2021-11-11

Comparison of Outcomes of Patients With Stage IV Chronic Limb-threatening Ischemia and Colorectal Cancer

Clinical Centre of Serbia

Completed
836 enrolled
Gastrointestinal

Chronic Limb-Threatening Ischemia, Colorectal Neoplasms, Peripheral Arterial Disease

NCT02819011 2020-02-27

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

Baylor College of Medicine

Phase 2 Completed
44 enrolled 16 charts

Frailty, Arthritis, Diabetes Mellitus, Neoplasms, Parkinson Disease, Peripheral Arterial Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡